Document is current
Any future updates will be listed below
-
Authors
Dohr, Johannes https://orcid.org/0009-0009-3319-1337
Metze, Clemens
Körber, Maria Isabel
Schäfer, Matthieu
Nienaber, Stephan
Curio, Jonathan
Nies, Richard
Baldus, Stephan
Pfister, Roman
Iliadis, Christos
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 13 June 2025
Accepted: 21 February 2026
First Online: 12 March 2026
Declarations
:
: RP has a speaker engagement with Abbott Vascular and is a consultant for Edwards Lifesciences; SB received unrestricted research grant for the MATTERHORN trial – Abbott Vascular, a research grant from AstraZeneca and consultant honoraria from Edwards Lifesciences; MIK has received travel support by Abbott and Edwards Lifesciences and consultant honoraria by Abbott Vascular and Edwards Lifesciences. CI has received travel support by Abbott and Edwards Lifesciences and consultant honoraria by Abbott Vascular and Edwards Lifesciences. The remaining authors have no conflicts of interest to declare and none of the authors reports competing interest in the context of this manuscript.
